Quest Diagnostics Inc (DGX) stock
DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/3010% above fair value
$259.60−0.05 (-0.02%)
Close on Nov 13, 2026Market cap $28.56BP/E 25.9Yield –
Quest Diagnostics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Quest Diagnostics's profit margin for the twelve months ending Sep 30, 2026 was 9.5%. For fiscal 2025 it was 9.0%, against 8.8% the year before. The highest annual figure on record is 18.5% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9.0% | +0.2 |
| FY2024 | Dec 31, 2024 | 8.8% | −0.4 |
| FY2023 | Dec 31, 2023 | 9.2% | −0.3 |
| FY2022 | Dec 31, 2022 | 9.6% | −8.9 |
| FY2021 | Dec 31, 2021 | 18.5% | +3.3 |
| FY2020 | Dec 31, 2020 | 15.2% | +4.1 |
| FY2019 | Dec 31, 2019 | 11.1% | +1.3 |
| FY2018 | Dec 31, 2018 | 9.8% | −0.7 |
| FY2017 | Dec 31, 2017 | 10.4% | +1.5 |
| FY2016 | Dec 31, 2016 | 8.9% | −0.5 |
| FY2015 | Dec 31, 2015 | 9.5% | +2.0 |
| FY2014 | Dec 31, 2014 | 7.5% | −4.4 |
| FY2013 | Dec 31, 2013 | 11.9% | +4.3 |
| FY2012 | Dec 31, 2012 | 7.5% | +1.2 |
| FY2011 | Dec 31, 2011 | 6.4% | −3.6 |
| FY2010 | Dec 31, 2010 | 9.9% | +0.1 |
| FY2009 | Dec 31, 2009 | 9.8% | +1.8 |
| FY2008 | Dec 31, 2008 | 8.0% | +3.0 |
| FY2007 | Dec 31, 2007 | 5.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 10.1% | +1.4 |
| Q2 FY2026 | Jun 30, 2026 | 10.5% | +0.3 |
| Q1 FY2026 | Mar 31, 2026 | 8.7% | +0.4 |
| Q4 FY2025 | Dec 31, 2025 | 8.7% | +0.3 |
| Q3 FY2025 | Sep 30, 2025 | 8.7% | −0.4 |
| Q2 FY2025 | Jun 30, 2025 | 10.2% | +0.7 |
| Q1 FY2025 | Mar 31, 2025 | 8.3% | +0.1 |
| Q4 FY2024 | Dec 31, 2024 | 8.5% | +0.1 |
| Q3 FY2024 | Sep 30, 2024 | 9.1% | −0.7 |
| Q2 FY2024 | Jun 30, 2024 | 9.6% | −0.5 |
| Q1 FY2024 | Mar 31, 2024 | 8.2% | −0.5 |
| Q4 FY2023 | Dec 31, 2023 | 8.4% | +4.1 |
| Q3 FY2023 | Sep 30, 2023 | 9.8% | −0.5 |
| Q2 FY2023 | Jun 30, 2023 | 10.1% | +0.5 |
| Q1 FY2023 | Mar 31, 2023 | 8.7% | −4.9 |
| Q4 FY2022 | Dec 31, 2022 | 4.3% | −9.9 |
| Q3 FY2022 | Sep 30, 2022 | 10.3% | −7.9 |
| Q2 FY2022 | Jun 30, 2022 | 9.5% | −15.2 |
| Q1 FY2022 | Mar 31, 2022 | 13.6% | −3.6 |
| Q4 FY2021 | Dec 31, 2021 | 14.2% | −5.1 |
| Q3 FY2021 | Sep 30, 2021 | 18.2% | −2.2 |
| Q2 FY2021 | Jun 30, 2021 | 24.7% | +14.6 |
| Q1 FY2021 | Mar 31, 2021 | 17.2% | +11.8 |
| Q4 FY2020 | Dec 31, 2020 | 19.3% | +6.2 |
| Q3 FY2020 | Sep 30, 2020 | 20.4% | +9.4 |
| Q2 FY2020 | Jun 30, 2020 | 10.1% | −1.4 |
| Q1 FY2020 | Mar 31, 2020 | 5.4% | −3.2 |
| Q4 FY2019 | Dec 31, 2019 | 13.1% | +6.2 |
| Q3 FY2019 | Sep 30, 2019 | 11.0% | −0.3 |
| Q2 FY2019 | Jun 30, 2019 | 11.6% | +0.2 |
| Q1 FY2019 | Mar 31, 2019 | 8.7% | −0.7 |
| Q4 FY2018 | Dec 31, 2018 | 6.9% | −6.7 |
| Q3 FY2018 | Sep 30, 2018 | 11.3% | +2.6 |
| Q2 FY2018 | Jun 30, 2018 | 11.4% | +1.1 |
| Q1 FY2018 | Mar 31, 2018 | 9.4% | +0.4 |
| Q4 FY2017 | Dec 31, 2017 | 13.6% | +5.3 |
| Q3 FY2017 | Sep 30, 2017 | 8.7% | – |
| Q2 FY2017 | Jun 30, 2017 | 10.4% | – |
| Q1 FY2017 | Mar 31, 2017 | 9.0% | – |
| Q4 FY2016 | Dec 31, 2016 | 8.3% | – |
See a number that looks wrong?